Image Source: X
MedTech startup MedVital has raised ₹8.4 crore in a pre-seed funding round led by Nihar Parikh’s 4point0 Health Ventures, with participation from leading healthcare and logistics entrepreneurs, including the founders of Tata 1mg, NephroPlus, SafeExpress, Eye Q Hospital, Hexa Health, and AstroTalk.
Key Highlights:
Mission-Driven Innovation: MedVital is building India’s first integrated platform for advanced wound care and minimally invasive aesthetics, targeting the growing burden of chronic wounds from diabetes, obesity, trauma, and the rising demand for non-invasive cosmetic treatments.
Flagship Product: The company’s NoWound device is a compact, digitally enabled, Made-in-India Negative Pressure Wound Therapy (NPWT) system. Designed for hospitals, clinics, and home-care, it enables precision healing even in low-resource settings.
Strategic Use of Funds: The fresh capital will expand MedVital’s product portfolio, bolster its supply chain, and extend distribution to tertiary hospitals, rural clinics, and home-based care. The company is set to launch liquid chitosan-based wound dressings and enter the dermal and hair regeneration segments soon.
Leadership Vision: Co-founders Dr. Varun Gupta and Tarun Bansal emphasized their goal to position India as a global innovation hub for wound care, making advanced, outcome-driven solutions accessible and affordable across the healthcare ecosystem.
Investor Confidence: Nihar Parikh of 4point0 Health Ventures highlighted MedVital’s unique, clinically rigorous, and accessible approach to chronic wound care and aesthetics, aligning with the fund’s mission to back impactful healthcare innovation.
With this funding, MedVital is poised to redefine skin repair and restoration, bridging critical gaps in both therapeutic and aesthetic care.
Sources: BW Healthcare World, Entrackr, Indian Startup News
Advertisement
Advertisement
